Hydroxychloroquine in IgA nephropathy: a systematic review
Background Hydroxychloroquine (HCQ) has recently been reported to be a promising and safe anti-proteinuric agent for IgA nephropathy (IgAN) patients. In the present systematic review, we aimed to summarize the evidence concerning the benefits and risks of HCQ therapy in IgAN. Methods Electronic data...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Taylor & Francis Group
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/a21e508e22924ad9b6fa8d86af66496c |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|